Improved Survival of a HER2-Positive Metastatic Breast Cancer Patient Following a Personalized Peptide Immunization.

Schönharting, Wolfgang; Roehnisch, Tim; Manoochehri, Mehdi; Christoph, Jan; Sieger, Marie; Nogueira, Mauro; Martos-Contreras, Mari Carmen; Kunz, Meik

Schönharting, Wolfgang; Roehnisch, Tim; Manoochehri, Mehdi; Christoph, Jan; Sieger, Marie; Nogueira, Mauro; Martos-Contreras, Mari Carmen; Kunz, Meik.

Afiliação

Schönharting W; PMCR GmbH, 76135 Karlsruhe, Germany.
Roehnisch T; Interdisziplinäres Onkologisches Zentrum (IOZ), 80336 Munich, Germany.
Manoochehri M; PMCR GmbH, 76135 Karlsruhe, Germany.
Christoph J; PMCR GmbH, 76135 Karlsruhe, Germany.
Sieger M; AG Bio-Medical Data Science, Martin-Luther-Universität Halle-Wittenberg, 06108 Halle, Germany.
Nogueira M; Chair of Medical Informatics, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, 91054 Erlangen, Germany.
Martos-Contreras MC; PMCR GmbH, 76135 Karlsruhe, Germany.
Kunz M; PMCR GmbH, 76135 Karlsruhe, Germany.

Vaccines (Basel) ; 11(6)2023 May 25.

Article em En | MEDLINE | ID: mdl-37376412

Palavras-chave

bioinformatics; breast cancer; case report; immunotherapy; neoantigen; peptide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google